Overview

This trial is active, not recruiting.

Condition colonoscopy procedure
Treatment motus gi cleanc device
Sponsor Motus GI Medical Technologies Ltd
Start date July 2014
End date October 2015
Trial size 6 participants
Trial identifier NCT02161536, CP-MCC-SA-0214

Summary

The purpose of this study is evaluate the Motus GI Colon Cleansing system performance.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose screening
Arm
(Experimental)
motus gi cleanc device

Primary Outcomes

Measure
The count and percentage of colon segments BBPS>=2
time frame: Following the colonoscopic procedure- Up to 24 hours.

Eligibility Criteria

Male or female participants from 18 years up to 75 years old.

Inclusion Criteria: - Subjects in the age range of 18-75 years - Subjects with BMI within the range of 18.5-35 - Subject is willing to sign informed consent form Exclusion Criteria: - Active or severe IBD - Subjects with severe diverticulitis \ diverticular disease (known or detected) - Known or detected colonic stenosis - Known or detected bowel obstruction - History of prior colon surgery - ASA≥IV (sever systemic disease) - Sever Renal insufficiency - Sever Liver insufficiency - Contraindication for "colonoscopy" anesthesia \ sedation \ prep agent pregnancy - Subjects with altered mental status/inability to provide informed consent - Subject has a condition or is in a situation which in the investigators opinion may put the subject at significant risk, may confound the study results, or may interfere significantly

Trial information was received from ClinicalTrials.gov and was last updated in January 2015.
Information provided to ClinicalTrials.gov by Motus GI Medical Technologies Ltd.